Cell BiologybioRxivPreprint
ALK1-BMPRII agonism by clustering bispecific antibodies treats hereditary hemorrhagic telangiectasia
Sima Qutaina, Haitian Zhao, Zhiming Wang…·Philippe Marambaud
This study develops bispecific antibodies that activate the ALK1-BMPRII pathway, reducing AVMs and improving symptoms in HHT mouse models.
1 citation